TLR2 agonist (Genomics Institute of the Novartis Research Foundation)

N/A

Report date: 2025/03/20 09:42:15
NME

Base Information

Drug NameTLR2 agonist (Genomics Institute of the Novartis Research Foundation)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 modulators
TargetsToll like receptor 2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenomics Institute of the Novartis Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesGenomics Institute of the Novartis Research Foundation
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A